MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis.
暂无分享,去创建一个
A. Kernytsky | S. Choe | K. Marks | S. Gross | K. Kunii | Phong Quang | M. J. Cameron | J. Murtie | M. Dorsch | Z. Konteatis | S. Biller | Michelle F. Clasquin | Katya Marjon | E. Mandley | Michael McVay | Michelle L. Blake | J. Travins
[1] T. Golub,et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells , 2016, Science.
[2] Konstantinos J. Mavrakis,et al. Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5 , 2016, Science.
[3] R. DePinho,et al. Collateral Lethality: A new therapeutic strategy in oncology. , 2015, Trends in cancer.
[4] Pierre-Jacques Hamard,et al. Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis. , 2015, The Journal of clinical investigation.
[5] Robert A Copeland,et al. A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models. , 2015, Nature chemical biology.
[6] M. Looso,et al. Prmt5 is a regulator of muscle stem cell expansion in adult mice , 2015, Nature Communications.
[7] Alan Ashworth,et al. Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors. , 2015, Annual review of medicine.
[8] Guido Marcucci,et al. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma. , 2014, Cancer research.
[9] Claudio Agostinelli,et al. Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing* , 2013, The Journal of Biological Chemistry.
[10] Sanjeeb Kumar Sahu,et al. Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery , 2013, Genes & development.
[11] Ronan M. T. Fleming,et al. A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.
[12] Aiping Zhang,et al. Crystal structure of the human PRMT5:MEP50 complex , 2012, Proceedings of the National Academy of Sciences.
[13] Zhengxin Wang,et al. Protein arginine methyltransferase 5 is essential for growth of lung cancer cells. , 2012, The Biochemical journal.
[14] L. Chin,et al. Passenger Deletions Generate Therapeutic Vulnerabilities in Cancer , 2012, Nature.
[15] C. Bountra,et al. Epigenetic protein families: a new frontier for drug discovery , 2012, Nature Reviews Drug Discovery.
[16] Hans-Georg Breitinger,et al. Drug Synergy – Mechanisms and Methods of Analysis , 2012 .
[17] Ulrike Kutay,et al. The kinase activity of human Rio1 is required for final steps of cytoplasmic maturation of 40S subunits , 2012, Molecular biology of the cell.
[18] Zongyang Lv,et al. Structural insights into protein arginine symmetric dimethylation by PRMT5 , 2011, Proceedings of the National Academy of Sciences.
[19] A. Kamb,et al. Methylthioadenosine (MTA) Rescues Methylthioadenosine Phosphorylase (MTAP)-Deficient Tumors from Purine Synthesis Inhibition in Vivo via Non-Autonomous Adenine Supply , 2011 .
[20] B. Chait,et al. Protein Arginine Methyltransferase Prmt5-Mep50 Methylates Histones H2A and H4 and the Histone Chaperone Nucleoplasmin in Xenopus laevis Eggs* , 2011, The Journal of Biological Chemistry.
[21] G. Merlino,et al. Protein Arginine Methyltransferase 5 Regulates ERK1/2 Signal Transduction Amplitude and Cell Fate Through CRAF , 2011, Science Signaling.
[22] Gabriela Kalna,et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase , 2011, Nature.
[23] K. O. Elliston,et al. Chemogenetic Analysis of Human Protein Methyltransferases , 2011, Chemical biology & drug design.
[24] Chang-Hai Tsai,et al. Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation , 2011, Nature Cell Biology.
[25] M. Surani,et al. Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency. , 2010, Genes & development.
[26] G. Evans,et al. Growth and Metastases of Human Lung Cancer Are Inhibited in Mouse Xenografts by a Transition State Analogue of 5′-Methylthioadenosine Phosphorylase* , 2010, The Journal of Biological Chemistry.
[27] A. Sickmann,et al. RioK1, a New Interactor of Protein Arginine Methyltransferase 5 (PRMT5), Competes with pICln for Binding and Modulates PRMT5 Complex Composition and Substrate Specificity* , 2010, The Journal of Biological Chemistry.
[28] G. Evans,et al. Design and synthesis of potent "sulfur-free" transition state analogue inhibitors of 5'-methylthioadenosine nucleosidase and 5'-methylthioadenosine phosphorylase. , 2010, Journal of medicinal chemistry.
[29] Peter J. Oefner,et al. Quantification of intermediates of the methionine and polyamine metabolism by liquid chromatography-tandem mass spectrometry in cultured tumor cells and liver biopsies. , 2010, Journal of chromatography. A.
[30] S. Bao,et al. Methylation of Ribosomal Protein S10 by Protein-arginine Methyltransferase 5 Regulates Ribosome Biogenesis* , 2010, The Journal of Biological Chemistry.
[31] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[32] G. V. Van Duyne,et al. Role of pICLn in Methylation of Sm Proteins by PRMT5 , 2009, The Journal of Biological Chemistry.
[33] J. D. Benson,et al. Single-vector inducible lentiviral RNAi system for oncology target validation , 2009, Cell cycle.
[34] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[35] S. Carr,et al. A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology , 2008, Cell.
[36] C. Sardet,et al. The histone‐binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5 , 2008, EMBO reports.
[37] Kelly T Williams,et al. New insights into the regulation of methyl group and homocysteine metabolism. , 2007, The Journal of nutrition.
[38] A. Roidl,et al. Yeast Rio1p is the founding member of a novel subfamily of protein serine kinases involved in the control of cell cycle progression , 2002, Molecular microbiology.
[39] G. Meister,et al. Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln , 2001, Current Biology.
[40] Juri Rappsilber,et al. The Methylosome, a 20S Complex Containing JBP1 and pICln, Produces Dimethylarginine-Modified Sm Proteins , 2001, Molecular and Cellular Biology.
[41] S. Pestka,et al. The Human Homologue of the Yeast Proteins Skb1 and Hsl7p Interacts with Jak Kinases and Contains Protein Methyltransferase Activity* , 1999, The Journal of Biological Chemistry.
[42] Richard A. Ashmun,et al. Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.
[43] D. Vance,et al. Phosphatidylethanolamine N-methyltransferase from liver. , 1997, Biochimica et biophysica acta.
[44] G. Hannon,et al. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.
[45] J. Rowley,et al. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. , 1985, The New England journal of medicine.
[46] M. Robert-Gero,et al. Relationship between inhibition of protein methylase I and inhibition of Rous sarcoma virus-induced cell transformation. , 1979, Cancer research.
[47] J. Bertino,et al. Status of methylthioadenosine phosphorylase and its impact on cellular response to L-alanosine and methylmercaptopurine riboside in human soft tissue sarcoma cells. , 2004, Oncology research.
[48] T. Savarese,et al. Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines. , 1996, Cancer genetics and cytogenetics.
[49] F. Della Ragione,et al. Human 5'-deoxy-5'-methylthioadenosine phosphorylase: kinetic studies and catalytic mechanism. , 1988, Advances in experimental medicine and biology.